Zofran: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (outline) |
Notjusttired (talk | contribs) m (add study) |
||
| Line 1: | Line 1: | ||
{{stub}} | {{stub}} | ||
'''Zofran''' or '''ondansetron''' (generic name, oral) is drug used to treat [[nausea]] and vomiting.<ref name="drugscom">{{Cite web|url=https://www.drugs.com/zofran.html|title=Zofran Uses, Dosage & Side Effects|website=Drugs.com|language=en|access-date=2020-11-29}}</ref> Zofran is also sold under the brand names Zofran ODT and Zuplenz.<ref name="drugscom" /> | '''Zofran''' or '''ondansetron''' (generic name, oral) is drug used to treat [[nausea]] and vomiting.<ref name="drugscom">{{Cite web|url=https://www.drugs.com/zofran.html|title=Zofran Uses, Dosage & Side Effects|website=Drugs.com|language=en|access-date=2020-11-29}}</ref> It is a 5-HT3 receptor antagonist.<ref name=":0">{{Cite journal|last=Späth|first=M.|author-link=|last2=Färber, D.|first2=L.|author-link2=|last3=Welzel|first3=D.|author-link3=|last4=|first4=|author-link4=|last5=|first5=|author-link5=|last6=|first6=|author-link6=|last7=|first7=|last8=|first8=|date=2000-01-01|title=Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists - preliminary results|url=https://doi.org/10.1080/030097400750001851-1|journal=Scandinavian Journal of Rheumatology|volume=29|issue=113|pages=72–77|doi=10.1080/030097400750001851-1|issn=0300-9742|pmc=|pmid=|access-date=|quote=|via=}}</ref> Zofran is also sold under the brand names Zofran ODT and Zuplenz.<ref name="drugscom" /> | ||
==Theory== | ==Theory== | ||
| Line 21: | Line 21: | ||
==Costs and availability== | ==Costs and availability== | ||
== Notable studies == | |||
* 2009, Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists - preliminary results<ref name=":0" /> [https://doi.org/10.1080/030097400750001851-1 (Abstract)] | |||
== See also == | == See also == | ||
Revision as of 03:16, December 1, 2020
 | This article is a stub. |
Zofran or ondansetron (generic name, oral) is drug used to treat nausea and vomiting.[1] It is a 5-HT3 receptor antagonist.[2] Zofran is also sold under the brand names Zofran ODT and Zuplenz.[1]
Theory[edit | edit source]
Evidence[edit | edit source]
Clinicians[edit | edit source]
Risks and safety[edit | edit source]
Serious side effects may occur with zofran including:
- blurred vision or vision loss (lasting from a few minutes to several hours)
- Slowed heart rate
- Difficultty breathing
- Anxiety
- Agitation
- Shivering
- feeling like you might pass out
- Urinating less than usual or not urinating at all
Zofran may impair your thinking or reactions, which may make driving unsafe.[1]
Costs and availability[edit | edit source]
Notable studies[edit | edit source]
- 2009, Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists - preliminary results[2] (Abstract)
See also[edit | edit source]
Learn more[edit | edit source]
- Zofran - drugs.com
References[edit | edit source]
- ↑ 1.0 1.1 1.2 "Zofran Uses, Dosage & Side Effects". Drugs.com. Retrieved November 29, 2020.
- ↑ 2.0 2.1 Späth, M.; Färber, D., L.; Welzel, D. (January 1, 2000). "Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists - preliminary results". Scandinavian Journal of Rheumatology. 29 (113): 72–77. doi:10.1080/030097400750001851-1. ISSN 0300-9742.
